Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help

  1. Font size

    Reduce font size Increase font size  
 
 
  1. Press Releases
  2. Sanofi US Press Kit
  3. News Alerts
  4. Media Contacts
  5. Multi Media Digital Center
 

Contact Us

Sanofi US
55 Corporate Drive
Bridgewater, NJ 08807

Tel: 800-981-2491


 

Via email

Press Releases

Our press releases are listed in chronological order and archived by year. To find press releases on a specific topic, utilize the search function.

Archives: Search / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005

Archives: Search / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005

Category: 

May 17, 2013
Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 16, 2013
Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
- Bettis Unveils New Playbook for Defending Against Severe Allergic Reactions and Urges Those Affected to Take Action -
May 6, 2013
New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem
The same trusted formula in an easy aim spray
May 6, 2013
Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength in Numbers"
-Donation to Diabetes Hands Foundation Doubled When Documentary Reaches 10,000 Views-
May 2, 2013
Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year
Growth platforms(2) sales increased 8.6%(3)
 

2013 Press Releases

Share

Print Email page RSS

Email information entered to email a page is only used to send the message and is not retained.

Corporate Information

Corporate Information


Executive Leadership

U.S. Headquarters
55 Corporate Drive
Bridgewater, NJ 08807
800-981-2491

U.S. Employee Count
11,400

Key Therapeutic Areas
Cardiovascular Diseases
Central Nervous System
Internal Medicine
Metabolic Disorders
Oncology
Ophthalmology
Thrombosis
Vaccines 

2010 Global R&D Investment
€4.4 Billion

2010 Global Sales
€30.4 Billion